Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial

Author:

van Zyl-Smit Richard N.1,Esmail Aliasgar1,Bateman Mary E.1,Dawson Rodney1,Goldin Jonathan2,van Rikxoort Eva3,Douoguih Macaya4,Pau Maria Grazia4,Sadoff Jerald C.4,McClain J. Bruce5,Snowden Margaret Ann5,Benko Jacqueline5,Hokey David A.5,Rutkowski Kathryn Tucker5,Graves Andrew5,Shepherd Barbara5,Ishmukhamedov Sadritdin5,Kagina Benjamin M. N.67,Abel Brian68,Hanekom Willem A.6,Scriba Thomas J.6,Bateman Eric D.1ORCID

Affiliation:

1. University of Cape Town Lung Institute, Division of Pulmonology, Department of Medicine

2. UCLA Medical Centre, Los Angeles, California

3. Department of Radiology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands

4. Crucell Holland B.V., a Janssen Pharmaceutical company of Johnson & Johnson, Leiden, the Netherlands

5. Aeras, Rockville, Maryland; and

6. South African TB Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, and

7. Vaccines for Africa Initiative, Division of Medical Microbiology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa

8. Singapore Immunology Network, Agency for Science, Technology and Research, Singapore

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3